Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

AMGEN CORPORATION — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

AMGEN CORPORATION

via WINSTEAD PC

3rd Quarter (July 1 - Sep 30) · 2008Posted Oct 17, 2008Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: AMGEN CORPORATION
Location: California · United States of America

Registrant

Firm: WINSTEAD PC
Description: Law Firm
Location: Austin, Texas, United States of America

Lobbying activities

2 issues

Medicare/Medicaid
Medicare coverage and reimbursement
LobbyistsJAMES L BAYLESS jr · WILLIAM N LAFORGE
Covered position (JAMES L BAYLESS jr): Shareholder
Covered position (WILLIAM N LAFORGE): Shareholder
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Intellectual Property and Process Patent Issues
LobbyistsJAMES L BAYLESS jr · WILLIAM N LAFORGE
Covered position (JAMES L BAYLESS jr): Shareholder
Covered position (WILLIAM N LAFORGE): Shareholder
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.